Formulation change in VLCD in response to DHSS recommendations: comparative evaluation.

Area of Science:

• Nutritional Science
• Dietary Interventions
• Clinical Nutrition

Background:

• The Cambridge diet was reformulated from 330 kcal to 405 kcal with 42g protein in response to policy recommendations.
• Clinical performance of very low-calorie diets (VLCDs) at similar calorie levels requires validation.
• Previous VLCD formulations have established safety and efficacy profiles.

Purpose of the Study:

• To evaluate the efficacy and safety of a reformulated 405 kcal Cambridge diet.
• To compare weight loss and body composition changes between the original and reformulated VLCDs.
• To assess the impact of the reformulated VLCD on blood parameters.

Main Methods:

• A comparative study involving female subjects using the original (330 kcal) and reformulated (405 kcal) Cambridge diet formulations.
• Weight loss and fat-free mass (FFM) percentage were measured over 2 and 8-week periods.
• Comprehensive blood analyses were conducted before and after the 8-week intervention.

Main Results:

• No significant difference in weight loss was observed between the original and reformulated diets over 2 or 8 weeks.
• The percentage of body weight represented by FFM increased by 5% in both groups after 8 weeks.
• All blood parameters remained within the normal range, with iron levels improving from below normal to normal.

Conclusions:

• The reformulated 405 kcal Cambridge diet, with 42g protein, demonstrates comparable efficacy and safety to the original 330 kcal formulation.
• The increased calorie and protein content did not negatively impact clinical performance or blood profiles.
• The VLCD formulation is safe and effective for weight management, maintaining key physiological markers.